ASC36+ASC35

N/A

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameASC36+ASC35
Drug Alias NameASC36/ASC35ASC36 and ASC35ASC35/ASC36ASC35 and ASC36ASC35+ASC36
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAmylin receptor agonistsGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonists
TargetsAmylin ReceptorGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes ASC-36ASC-35
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAscletis Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAscletis Pharma Inc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A